Search

everythinglearnresearchcommunity

for

Search:↓

Low-dose oral minoxidil combined with topical minoxidil improves hair density in breast cancer patients but may cause excess hair growth.

Treatment with 5α-reductase inhibitors is linked to a delay in prostate cancer diagnosis and may affect survival rates.

Ritlecitinib improves emotional well-being and activity levels in alopecia areata patients.

High-dose dutasteride reduces PMDD symptoms by stabilizing neurosteroid levels.

Dutasteride can stabilize hair loss in patients with frontal fibrosing alopecia, but its safety in women is unclear, so use it with caution.

Hormonal treatments, including birth control and antiandrogens, can effectively treat acne in women.

Finasteride and dutasteride are effective in treating male hair loss but can cause sexual side effects and birth defects.

Patients with fewer past treatments for alopecia areata respond better to baricitinib.

Antiandrogens can help treat female pattern hair loss.

Rare ovarian tumors can cause hyperandrogenism, even if imaging appears normal.

Upadacitinib is effective and safe for treating severe alopecia areata in teens.

Combining conventional and integrative treatments can help reduce hair loss and improve hair growth in women with androgenic alopecia.

Actemra is approved for a specific artery condition, HIV treatment adherence has improved, women may pay more for a hair loss product, and incorrect dosing of blood thinners can be risky.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

The combination of tadalafil and finasteride improves urinary symptoms and erectile function in men with enlarged prostates.

Testosterone therapy can safely and effectively treat symptoms like low libido and fatigue in women, especially after menopause.

Hormonal therapy like cyproterone acetate and spironolactone may help female hair loss, but more research is needed, especially for pre-menopausal women.

Dutasteride is effective for treating prostate enlargement and reducing related surgery risk, but is not approved for preventing prostate cancer.

Estrogen alone may effectively suppress testosterone in some transfeminine individuals.

Using tretinoin with triamcinolone acetonide helps treat alopecia areata.

Removing the ovarian tumor improved the woman's hormonal symptoms.

Combining flutamide and finasteride can reduce prostate weight and tumor growth, potentially benefiting treatments needing optimal DHT inhibition.

3α-AdiolG is a good marker for androgen activity in women with excessive hair growth and decreases with anti-androgen treatment.

Skin patting and iontophoresis with dutasteride gel improved hair growth in people with androgenetic alopecia.

Androgens and SARMs play a role in body mass, frailty, skin health, and hair growth, and are used in treating prostate cancer, acne, and hair loss, with potential for new uses and improved versions in the future.

Hormone treatment for transsexual individuals is effective but carries risks like thromboembolic events and mood changes, with most side effects being minor and reversible.

Testosterone therapy for postmenopausal women appears safe and may protect against heart disease, but requires constant monitoring and more research for long-term effects.